A 17 year old girl in the 4th month of pregnancy presents with vaginal bleeding, accompanied by passage of grapelike tissue fragments. Plasma human chorionic gonadotropin (hCG) is very high.Following ultrasound evaluation, dilatation and curettage is performed. Histologic examination shows diffuse trophoblastic proliferation and edema in all chorionic villi. Cytogenetic studies demonstrate 46, XY karyotype. Clinical studies show that this condition progresses to choriocarcinoma at a rate of?

## **Core Concept**
The clinical presentation described points towards a diagnosis of **hydatidiform mole**, a type of gestational trophoblastic disease (GTD) characterized by abnormal trophoblastic proliferation and hydropic degeneration of chorionic villi. The presence of a high plasma human chorionic gonadotropin (hCG) level and the ultrasound findings further support this diagnosis. The condition is often associated with a **complete mole**, which typically has a diploid karyotype, commonly 46,XX, but can also be 46,XY as seen in this case.

## **Why the Correct Answer is Right**
The progression of hydatidiform mole to **choriocarcinoma**, a malignant form of gestational trophoblastic neoplasia (GTN), is a known complication. The risk of progression to choriocarcinoma is higher in complete moles compared to partial moles. Studies have shown that approximately **1-2%** of patients with a hydatidiform mole will develop choriocarcinoma. This risk is critical in guiding the follow-up and management of patients after the evacuation of a molar pregnancy.

## **Why Each Wrong Option is Incorrect**
- **Option A (10-20%)**: This option overestimates the risk of progression from hydatidiform mole to choriocarcinoma. While there is a risk of malignant transformation, the actual percentage is much lower.
- **Option B (20-30%)**: Similar to option A, this significantly overestimates the risk and does not accurately reflect the known clinical data on the progression to choriocarcinoma.
- **Option D (50-60%)**: This option grossly overestimates the risk. The actual risk is much lower, and such a high progression rate would be unusual for this condition.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that **all patients with a hydatidiform mole require follow-up with serial hCG levels** after evacuation to monitor for potential progression to gestational trophoblastic neoplasia (GTN), including choriocarcinoma. This follow-up is crucial for early detection and treatment of any persistent gestational trophoblastic disease.

## **Correct Answer: B. 1-2%.**